About Anagenex
Anagenex is a company based in San Francisco (United States) founded in 2019 by Nicolas Tilmans.. Anagenex has raised $30 million across 2 funding rounds from investors including Khosla Ventures, Catalio Capital Management and Lux Capital. The company has 23 employees as of December 31, 2022. Anagenex offers products and services including AI Drug Discovery Platform. Anagenex operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
- Headquarter San Francisco, United States
- Employees 23 as on 31 Dec, 2022
- Founders Nicolas Tilmans
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Anagenex, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30 M (USD)
in 2 rounds
-
Latest Funding Round
$30 M (USD), Series A
Jun 08, 2022
-
Investors
Khosla Ventures
& 5 more
-
Employee Count
23
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Anagenex
Anagenex offers a comprehensive portfolio of products and services, including AI Drug Discovery Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform tests billions of molecules for disease treatments and AI refinement.
Unlock access to complete
Unlock access to complete
Leadership Team
3 people
Independent Team
1 people
Research Team
1 people
Principal Team
1 people
Unlock access to complete
Funding Insights of Anagenex
Anagenex has successfully raised a total of $30M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $30 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $30.0M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Series A - Anagenex | Valuation | Catalio Capital Management | |
| Jun, 2020 | Amount | Seed - Anagenex | Valuation | Lux Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Anagenex
Anagenex has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Catalio Capital Management and Lux Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to biomedical technology startups.
|
Founded Year | Domain | Location | |
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Anagenex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Anagenex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Anagenex Comparisons
Competitors of Anagenex
Anagenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An agentic AI platform is developed for biomedical research insights.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| domain | founded_year | HQ Location |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| domain | founded_year | HQ Location |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| domain | founded_year | HQ Location |
AI platform used for extracting antibody data from scientific papers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Anagenex
Frequently Asked Questions about Anagenex
When was Anagenex founded?
Anagenex was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Anagenex located?
Anagenex is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Anagenex?
Nicolas Tilmans is the current CEO of Anagenex. They have also founded this company.
Is Anagenex a funded company?
Anagenex is a funded company, having raised a total of $30M across 2 funding rounds to date.
How many employees does Anagenex have?
As of Dec 31, 2022, the latest employee count at Anagenex is 23.
What does Anagenex do?
Anagenex was founded in 2019 and is headquartered in San Francisco, United States. Drug discovery services are provided through manufacturing processes in the biotechnology sector. Operations center on supporting pharmaceutical research and development needs. The company is led by Nicolas Tilmans, who serves as Founder and CEO. Focus remains on efficient service delivery for industry clients in the region.
Who are the top competitors of Anagenex?
Anagenex's top competitors include Owkin, Formation Bio and XtalPi.
What products or services does Anagenex offer?
Anagenex offers AI Drug Discovery Platform.
Who are Anagenex's investors?
Anagenex has 6 investors. Key investors include Khosla Ventures, Catalio Capital Management, Lux Capital, Obvious Ventures, and Air Street Capital.